HUP0302307A2 - Görcsellenes aktivitású származékok a II. típusú diabétesz mellitusz és az X-szindróma megelőzésére - Google Patents
Görcsellenes aktivitású származékok a II. típusú diabétesz mellitusz és az X-szindróma megelőzéséreInfo
- Publication number
- HUP0302307A2 HUP0302307A2 HU0302307A HUP0302307A HUP0302307A2 HU P0302307 A2 HUP0302307 A2 HU P0302307A2 HU 0302307 A HU0302307 A HU 0302307A HU P0302307 A HUP0302307 A HU P0302307A HU P0302307 A2 HUP0302307 A2 HU P0302307A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl group
- syndrome
- development
- diabetes mellitus
- preventing
- Prior art date
Links
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 230000001773 anti-convulsant effect Effects 0.000 title 1
- 239000001961 anticonvulsive agent Substances 0.000 title 1
- 229960003965 antiepileptics Drugs 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 125000002009 alkene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- -1 methylenedioxy group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány tárgya az (I) általános képletű vegyületek alkalmazásaemlősben II. típusú diabétesz mellitusz, X-szindróma, kóros orálisglükóz tolerancia és sérült inzulinérzékenység kezelésére vagyesetenként kialakulásának megelőzésére alkalmas gyógyászati készítményelőállítására - a képletben X jelentése CH2 vagy oxigénatom, R1jelentése hidrogénatom vagy alkilcsoport és R2, R3, R4 vagy R5jelentése egymástól függetlenül hidrogénatom vagy kis szénatomszámúalkilcsoport, és amennyiben X jelentése CH2, akkor R4 és R5 jelentéseegyüttesen lehet egy benzolgyűrűt kialakító alkéncsoport, ésamennyiben X jelentése oxigénatom, R2 és R3 és/vagy R4 és R5együttesen egy (II) általános képletű metiléndioxi-csoportot alkothat,ahol R6 és R7 jelentése azonosan vagy különbözően hidrogénatom; kisszénatomszámú alkicsoport vagy az R6 és R7 együttesen ciklopentil-vagy ciklohexil-gyűrűt kialakító alkilcsoportot jelentenek. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21714100P | 2000-07-07 | 2000-07-07 | |
| US27002201P | 2001-02-20 | 2001-02-20 | |
| PCT/US2001/021404 WO2002003984A2 (en) | 2000-07-07 | 2001-07-06 | Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0302307A2 true HUP0302307A2 (hu) | 2003-10-28 |
| HUP0302307A3 HUP0302307A3 (en) | 2007-05-29 |
Family
ID=26911655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0302307A HUP0302307A3 (en) | 2000-07-07 | 2001-07-06 | Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6852701B2 (hu) |
| EP (1) | EP1309324B1 (hu) |
| JP (1) | JP4920163B2 (hu) |
| CN (1) | CN101404993A (hu) |
| AR (1) | AR032465A1 (hu) |
| AT (1) | ATE320805T1 (hu) |
| AU (1) | AU2001280486A1 (hu) |
| BR (1) | BR0112519A (hu) |
| CA (1) | CA2415093A1 (hu) |
| DE (1) | DE60118206T2 (hu) |
| DK (1) | DK1309324T3 (hu) |
| ES (1) | ES2260261T3 (hu) |
| HU (1) | HUP0302307A3 (hu) |
| IL (1) | IL153713A0 (hu) |
| MX (1) | MXPA03000136A (hu) |
| MY (1) | MY126897A (hu) |
| NO (1) | NO20030064L (hu) |
| NZ (1) | NZ523531A (hu) |
| PL (1) | PL365680A1 (hu) |
| PT (1) | PT1309324E (hu) |
| RU (1) | RU2268720C2 (hu) |
| WO (1) | WO2002003984A2 (hu) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080255093A1 (en) * | 1999-06-14 | 2008-10-16 | Tam Peter Y | Compositions and methods for treating obesity and related disorders |
| US7674776B2 (en) * | 1999-06-14 | 2010-03-09 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
| US20080103179A1 (en) * | 2006-10-27 | 2008-05-01 | Tam Peter Y | Combination Therapy |
| AU2003297639A1 (en) * | 2002-12-02 | 2004-06-23 | University Of Florida | Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| MY142329A (en) * | 2004-08-24 | 2010-11-15 | Janssen Pharmaceutica Nv | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents. |
| KR20080012360A (ko) * | 2005-05-20 | 2008-02-11 | 얀센 파마슈티카 엔.브이. | 설파미드 유도체의 제조 방법 |
| US8497298B2 (en) * | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| US20070155823A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| US8716231B2 (en) * | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US8492431B2 (en) * | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| US20070155827A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| US20070191461A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine |
| US20070191449A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression |
| US20070191459A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels |
| US20070191453A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction |
| US20070191474A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine |
| TW200812573A (en) * | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
| US9744137B2 (en) | 2006-08-31 | 2017-08-29 | Supernus Pharmaceuticals, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| AU2007319141B2 (en) | 2006-11-17 | 2013-01-10 | Supernus Pharmaceuticals Inc. | Sustained-release formulations of topiramate |
| MX2009003911A (es) * | 2006-12-04 | 2009-05-28 | Supernus Pharmaceuticals Inc | Formulaciones de liberacion inmediata, mejoradas de topiramato. |
| NO2106260T3 (hu) * | 2007-01-25 | 2018-05-05 | ||
| US20090076128A1 (en) * | 2007-09-15 | 2009-03-19 | Protia Llc | Deuterium-enriched topiramate |
| US20090247616A1 (en) * | 2008-03-26 | 2009-10-01 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety |
| US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
| US8580298B2 (en) * | 2008-06-09 | 2013-11-12 | Vivus, Inc. | Low dose topiramate/phentermine composition and methods of use thereof |
| US20090304789A1 (en) | 2008-06-09 | 2009-12-10 | Thomas Najarian | Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders |
| US8809385B2 (en) | 2008-06-23 | 2014-08-19 | Janssen Pharmaceutica Nv | Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
| CN103316026B (zh) | 2012-03-23 | 2016-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 含芬特明和托吡酯的联合产品及其制备方法 |
| CN102579367B (zh) | 2012-03-23 | 2014-03-12 | 中国人民解放军军事医学科学院毒物药物研究所 | 托吡酯缓释药物组合物、其制备方法及用途 |
| CN104220064B (zh) | 2012-03-23 | 2017-10-10 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种含辛弗林和托吡酯的联合产品 |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| US10278948B1 (en) | 2015-09-03 | 2019-05-07 | Tian Xia | Method for transnasal delivery of anticonvulsant and therapeutic treatments |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| IL103172A (en) * | 1991-09-19 | 1997-01-10 | Mcneilab Inc | Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol |
| US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| US5384327A (en) | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
| CA2258893C (en) * | 1996-06-28 | 2005-06-14 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant sulfamate derivatives useful in treating obesity |
| UA65607C2 (uk) | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
| AU779248B2 (en) | 1999-02-24 | 2005-01-13 | University Of Cincinnati, The | Use of sulfamate derivatives for treating impulse control disorders |
| JP2003530300A (ja) | 1999-04-08 | 2003-10-14 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 体重低下を維持することに有用な抗痙攣薬誘導体 |
| NZ514811A (en) * | 1999-04-08 | 2005-01-28 | Ortho Mcneil Pharm Inc | Anticonvulsant derivatives useful in reducing blood glucose levels |
| JP2002541199A (ja) * | 1999-04-08 | 2002-12-03 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 脂質を下げることに有用な抗痙攣薬誘導体 |
| CA2686633A1 (en) * | 1999-06-14 | 2000-12-21 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
-
2001
- 2001-07-06 CA CA002415093A patent/CA2415093A1/en not_active Abandoned
- 2001-07-06 PT PT01958878T patent/PT1309324E/pt unknown
- 2001-07-06 AT AT01958878T patent/ATE320805T1/de active
- 2001-07-06 CN CNA018151590A patent/CN101404993A/zh active Pending
- 2001-07-06 DE DE60118206T patent/DE60118206T2/de not_active Expired - Lifetime
- 2001-07-06 WO PCT/US2001/021404 patent/WO2002003984A2/en active IP Right Grant
- 2001-07-06 US US09/900,567 patent/US6852701B2/en not_active Expired - Lifetime
- 2001-07-06 AU AU2001280486A patent/AU2001280486A1/en not_active Abandoned
- 2001-07-06 MX MXPA03000136A patent/MXPA03000136A/es active IP Right Grant
- 2001-07-06 EP EP01958878A patent/EP1309324B1/en not_active Expired - Lifetime
- 2001-07-06 DK DK01958878T patent/DK1309324T3/da active
- 2001-07-06 PL PL01365680A patent/PL365680A1/xx not_active Application Discontinuation
- 2001-07-06 NZ NZ523531A patent/NZ523531A/en unknown
- 2001-07-06 BR BR0112519-2A patent/BR0112519A/pt not_active IP Right Cessation
- 2001-07-06 ES ES01958878T patent/ES2260261T3/es not_active Expired - Lifetime
- 2001-07-06 HU HU0302307A patent/HUP0302307A3/hu unknown
- 2001-07-06 MY MYPI20013235 patent/MY126897A/en unknown
- 2001-07-06 IL IL15371301A patent/IL153713A0/xx unknown
- 2001-07-06 JP JP2002508438A patent/JP4920163B2/ja not_active Expired - Lifetime
- 2001-07-06 RU RU2003100076/14A patent/RU2268720C2/ru not_active IP Right Cessation
- 2001-07-10 AR ARP010103263A patent/AR032465A1/es not_active Application Discontinuation
-
2003
- 2003-01-06 NO NO20030064A patent/NO20030064L/no not_active Application Discontinuation
-
2004
- 2004-05-11 US US10/843,134 patent/US7109174B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE320805T1 (de) | 2006-04-15 |
| CA2415093A1 (en) | 2002-01-17 |
| AU2001280486A1 (en) | 2002-01-21 |
| JP4920163B2 (ja) | 2012-04-18 |
| NO20030064L (no) | 2003-03-06 |
| CN101404993A (zh) | 2009-04-08 |
| IL153713A0 (en) | 2003-07-06 |
| JP2004510700A (ja) | 2004-04-08 |
| DK1309324T3 (da) | 2006-06-12 |
| MXPA03000136A (es) | 2004-09-13 |
| PL365680A1 (en) | 2005-01-10 |
| EP1309324B1 (en) | 2006-03-22 |
| WO2002003984A3 (en) | 2003-03-06 |
| ES2260261T3 (es) | 2006-11-01 |
| EP1309324A2 (en) | 2003-05-14 |
| DE60118206T2 (de) | 2006-12-14 |
| NZ523531A (en) | 2005-07-29 |
| MY126897A (en) | 2006-10-31 |
| US6852701B2 (en) | 2005-02-08 |
| NO20030064D0 (no) | 2003-01-06 |
| US20020037861A1 (en) | 2002-03-28 |
| RU2268720C2 (ru) | 2006-01-27 |
| PT1309324E (pt) | 2006-06-30 |
| BR0112519A (pt) | 2004-03-30 |
| AR032465A1 (es) | 2003-11-12 |
| WO2002003984A2 (en) | 2002-01-17 |
| HUP0302307A3 (en) | 2007-05-29 |
| US7109174B2 (en) | 2006-09-19 |
| US20040209824A1 (en) | 2004-10-21 |
| DE60118206D1 (de) | 2006-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302307A2 (hu) | Görcsellenes aktivitású származékok a II. típusú diabétesz mellitusz és az X-szindróma megelőzésére | |
| HUP0105154A2 (hu) | Cluster típusú fejfájás kezelésére alkalmas görcsoldószármazékok | |
| HUP0202655A2 (hu) | N-[(amino-imino-metil)- és N-[(amino-metil)-fenil]-propil-amid származékok | |
| HUP0400240A2 (hu) | Szubsztituált oxazolidinonszármazékok és más hatóanyagok kombinációi és ezeket tartalmazó gyógyszerkészítmények | |
| WO2000061139A8 (en) | Anticonvulsant derivatives useful in reducing blood glucose levels | |
| DE69325454D1 (de) | Taxol-derivate | |
| HUP0400837A2 (hu) | 2-feniltiazol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0003073A2 (hu) | Benzolszulfonamid-származékok, eljárás előállításukra és gyógyszerként való alkalmazásuk | |
| HUP0202017A2 (hu) | Új vegyületek | |
| HUP0103714A2 (hu) | Hipoglikémiás és hipolipidémiás hatással rendelkező oxiiminoalkánsavszármazékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0303037A2 (hu) | Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0102470A2 (hu) | Retinoidrokon receptorok funkcióját szabályozó 1,3-azol-származékok és alkalmazásuk | |
| HUP0100847A1 (hu) | Új aromás amidok, előállításuk, valamint alkalmazásuk gyógyászati készítmények előállítására | |
| HUP0303118A2 (hu) | Új 1,3-dihidro-2H-indolon-származékok, előállítási eljárásuk és azokat tartalmazó gyógyszerkészítmények | |
| HUP0402235A2 (hu) | 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0204354A2 (hu) | Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0303144A2 (hu) | Eljárások szubsztituált 2-(2-piridil-metil)-szulfinil-1H-benzimidazolok előállítására | |
| HUP9904294A2 (hu) | Topiramát származékok alkalmazása neuropátiás fájdalom kezelésére alkalmas gyógyszer előállítására | |
| IS1961B (is) | Notkun 1-(2-naft-2-ýletýl)-4(3-tríflúorómetýlfenýl)-1,2,3,6-tetrahýdrópýridíns til gerðar lyfja tilþess að meðhöndla hliðarstrengjahersli | |
| HUP0301176A2 (hu) | Eljárás a gyűrűben nitrogénatomot tartalmazó és N-1 nitrogénatomon védőcsoportot viselő, gyűrűs poliaminok és az ezekből készíthető termékek előállítása | |
| HUP0203538A2 (hu) | Új (4-hidroxi-bifenil)-hidrazid-származékok | |
| HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0303361A2 (hu) | Helyettesített 1-amino-bután-3-ol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP9904628A2 (hu) | Új imidazolinvegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyászatikészítmények | |
| HUP0402585A2 (hu) | Új benzotiazin- benzotiadiazin-származékok, előállításuk, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |